NL-OMON50901招募中2 期
Exendin PET/CT for imaging of paragangliomas - ENTRAP
ucleaire geneeskunde en radiologie0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Proven PGL with a single tumor detected using standard diagnostic imaging
- •No evidence of metastatic disease
- •SSTR PET performed
- •Scheduled for surgery
- •Able to sign informed consent
排除标准
- •Breast feeding
- •Pregnancy or the wish to become pregnant within 1 month
- •Calculated creatinine clearance below 40ml/min
- •Evidence of other malignancy than PGL in conventional imaging (suspicious
- •liver, bone and lung lesions)
- •Age < 18 years
- •Not able to sign informed consent
研究者
相似试验
招募中
2 期
Testing Exendin PET, a new imaging technique, for imaging paragangliomas2024-516755-40-00Stichting Radboud universitair medisch centrum10
终止
1 期
A study to see whether PET scans using a chemical called Exendin can detect metastatic prostate cancer.CancerACTRN12619000791134Mark S Stein Pty Ltd4
已完成
1 期
A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2MProstate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancerJPRN-UMIN000015356niversity of Tsukuba15
尚未招募
不适用
[18F]PEG-Folate PET-CT imaging for monitoring of therapy response in Rheumatoid Arthritis patientsRheumatoid ArthritisNL-OMON26919GSK10
招募中
2 期
[18F]PEG-Folate PET-CT imaging for monitoring of therapy response in Rheumatoid Arthritis patientsRheumatoid arthritisNL-OMON52903Vrije Universiteit Medisch Centrum20